Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
alopecia
Biotech
Soterios looks to ph. 3 after win for alopecia areata cream
Soterios is eyeing phase 3 after a 1% dose of its alopecia areata cream improved severity of the condition, hitting the main goal of a mid-stage test.
James Waldron
May 30, 2024 8:14am
Amgen's lupus bets continue to tumble, even those on the Horizon
Jul 24, 2023 8:59am
Do hairy moles hold the key to treating hair loss?
Jun 22, 2023 5:01am
Sun's $576M Concert hits bum note as FDA imposes partial hold
May 2, 2023 7:09am
Concert persuades FDA to keep alopecia therapy breakthrough tag
Feb 15, 2023 10:00am
'Expect us to act' on M&A, AbbVie CEO says
Feb 9, 2023 2:29pm